Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesNeuronetics Inc

Neuronetics Inc

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
2.085 USD -0.10 ( 4.36%)
Last update at 2026-11-10T15:21:00Z
VOLUME
217206
Market Cap
213.35M

Momentum Score

…

Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. has a strategic collaboration with ANT Neuro to expand the capabilities of the NeuroStar advanced therapy system with advanced image-guided navigation technology. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
2.06
Low
2.22
High
52 Week Price Range
0.80
Low
3.44
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
2.18
Dividend Yield
-
Revenue TTM
155.10M
Revenue Per Share
2.23
Gross Profit TTM
76.59M
Debt / Equity
4.04
ROE
-116.10%
Net Debt
56.17M
ROCE
-27.54%
Diluted EPS TTM
-0.41

Insight News

View All

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -39.00M -43.74M -30.19M -37.16M -31.19M
Minority interest 0.14M 0.02M 0.00M - -
Net income -39.00M -43.71M -30.19M -39.21M -35.60M
Selling general administrative 49.70M 30.32M 25.43M 25.52M 25.55M
Selling and marketing expenses 47.46M 45.63M 47.32M 49.98M 37.75M
Gross profit 72.31M 54.16M 51.70M 49.72M 43.66M
Reconciled depreciation 3.46M 2.07M 2.01M 1.65M 1.06M
Ebit -30.58M -36.44M -24.77M -35.11M -27.56M
Ebitda -27.12M -34.37M -22.76M -31.26M -26.11M
Depreciation and amortization 3.46M 2.07M 2.01M 3.85M 1.45M
Non operating income net other - - - 2.20M -
Operating income -31.44M -34.56M -30.55M -35.11M -27.56M
Other operating expenses 180.59M 109.45M 101.90M 100.32M 82.88M
Interest expense 8.41M 7.29M 5.42M 4.25M 4.02M
Net interest income -8.40M -7.30M -5.40M -4.25M -4.02M
Income tax expense - -0.01M -0.02M 2.05M 4.41M
Total revenue 149.16M 74.89M 71.35M 65.21M 55.31M
Total operating expenses 103.74M 88.72M 82.26M 84.83M 71.22M
Cost of revenue 76.85M 20.73M 19.64M 15.48M 11.65M
Total other income expense net -7.56M -9.18M 0.36M -2.05M -3.63M
Net income from continuing ops -39.12M -43.74M -30.16M -37.16M -31.19M
Net income applicable to common shares - - - -37.16M -31.19M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 141.55M 140.90M 115.83M 116.88M 141.22M
Intangible assets 18.15M 19.61M 4.20M - -
Other current assets 5.97M 9.92M 7.28M 2.17M 4.65M
Total liab 115.31M 109.10M 81.64M 59.82M 56.05M
Total stockholder equity 22.38M 27.71M 34.19M 57.06M 85.17M
Deferred long term liab - - - 0.83M 6.76M
Other current liab 13.47M 13.80M 12.60M 14.84M 8.23M
Common stock 0.69M 0.56M 0.29M 0.27M 0.26M
Capital stock 0.69M 0.56M 0.29M 0.27M 0.26M
Retained earnings -458.79M -419.79M -376.08M -345.89M -308.73M
Other liab - - - 0.83M 1.47M
Good will 23.62M 18.63M - - -
Other assets - - 0.00M 9.20M 167.12M
Cash 34.13M 19.46M 59.68M 70.34M 94.14M
Total current liabilities 30.52M 31.27M 19.81M 33.20M 15.70M
Current deferred revenue 0.75M 0.97M 1.62M 1.98M 2.50M
Net debt 56.17M 63.17M 2.80M -30.59M -54.60M
Short term debt 5.56M 4.79M 0.84M 13.95M 0.67M
Short long term debt - - - 13.12M -
Short long term debt total 90.30M 82.63M 62.47M 39.74M 39.54M
Other stockholder equity 480.48M 446.94M 409.98M 402.68M 393.64M
Property plant equipment - - - 1.99M 5.10M
Total current assets 61.55M 58.12M 93.79M 98.77M 115.33M
Long term investments 0.10M 0.09M 0.66M 0.36M 1.70M
Net tangible assets - - - 57.06M 85.17M
Short term investments 0.23M 0.21M 0.91M 1.54M 2.20M
Net receivables 16.89M 24.29M 17.84M 13.82M 7.78M
Long term debt 65.81M 55.15M 59.28M 22.83M 35.34M
Inventory 4.33M 4.25M 8.09M 8.90M 6.56M
Accounts payable 10.74M 11.08M 4.75M 2.43M 4.30M
Common stock total equity - - - 0.27M -
Retained earnings total equity - - - -345.89M -
Non currrent assets other 9.95M 11.12M 12.80M 11.57M 19.09M
Non current assets total 80.00M 82.78M 22.04M 18.11M 25.89M
Capital lease obligations 24.50M 27.48M 3.19M 3.79M 4.21M
Long term debt total - - - 22.83M -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -2.41M -1.32M 10.00M -9.84M
Change to liabilities - - - 4.64M 0.49M
Total cashflows from investing activities -0.80M -2.41M -1.32M 6.73M -9.84M
Net borrowings 9.79M -2.52M 23.80M -0.09M -
Total cash from financing activities 35.85M -6.81M 22.70M 0.21M 83.01M
Change to operating activities - - - 7.26M -0.63M
Net income -39.13M -43.73M -30.19M -37.16M -31.19M
Change in cash 14.68M -40.22M -10.66M -23.80M 45.18M
Begin period cash flow 19.46M 59.68M 70.34M 94.14M 48.96M
End period cash flow 34.13M 19.46M 59.68M 70.34M 94.14M
Total cash from operating activities -20.37M -31.00M -32.04M -30.74M -27.98M
Issuance of capital stock 29.01M 0.00M 0.00M 0.00M 80.97M
Depreciation 3.46M 2.07M 2.01M 1.65M 1.06M
Other cashflows from investing activities 0.03M 1.61M 1.05M 10.00M -7.49M
Change to inventory -0.40M 3.15M -1.10M -2.59M -3.44M
Change to account receivables 3.54M -3.73M -8.83M -6.32M -3.05M
Sale purchase of stock -1.73M 0.00M 0.00M 0.30M -
Other cashflows from financing activities -0.59M -4.29M -1.10M 6.73M 2.03M
Change to netincome - - - 8.75M 8.79M
Capital expenditures 0.80M 1.47M 2.37M 3.27M 2.35M
Change receivables - - - -6.32M -
Cash flows other operating - - - -0.41M -
Cash and cash equivalents changes - - - -23.80M -
Change in working capital 6.58M -6.81M -14.10M -4.78M -6.64M
Stock based compensation 6.85M 5.60M 7.32M 8.75M 7.87M
Other non cash items 1.87M 11.86M 2.93M 0.80M 0.92M
Free cash flow -21.18M -32.46M -34.41M -34.01M -30.34M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
STIM
Neuronetics Inc		 -0.10
4.36%		 2.08 - - 1.38 12.40 1.86 -2.02
ABT
Abbott Laboratories		 -1.17
1.06%		 109.34 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC		 -1.38
1.34%		 101.42 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation		 -6.18
1.90%		 319.55 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG		 0.56
1.12%		 50.41 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

Neuronetics Inc

Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. has a strategic collaboration with ANT Neuro to expand the capabilities of the NeuroStar advanced therapy system with advanced image-guided navigation technology. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

3222 Phoenixville Pike, Malvern, PA, United States, 19355

877 600 7555

https://neurostar.com/neuronetics

658

Name Title Year Born
Mr. Keith J. Sullivan Pres, CEO & Director 1958
Mr. Stephen J. Furlong M.S. Sr. VP, CFO & Treasurer 1965
Mr. W. Andrew Macan Sr. VP, Gen. Counsel, Chief Compliance Officer, Sec. & Member of Office of the Pres 1973
Ms. Sara Grubbs VP of Sales NA
Ms. Claire Sears VP of Marketing NA
Ms. Kara Thornton VP of HR & Sr. Director NA
Mr. Keith J. Sullivan President, CEO & Director 1958
Mr. Stephen J. Furlong M.S. Executive VP, CFO & Treasurer 1964
Mr. W. Andrew Macan Executive VP, GC, Chief Compliance Officer & Corporate Secretary 1973
Mr. Rusty Page Senior VP of Operations & Quality NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

No data available
No data available

Equity Sectors*

  • Basic Materials

    -2.54%

  • Communication Services

    +0.09%

  • Consumer Cyclical

    -0.16%

  • Consumer Defensive

    -0.14%

  • Energy

    -1.11%

  • Financial Services

    +0.15%

  • Healthcare

    -0.77%

  • Industrials

    -0.93%

  • Real Estate

    -0.17%

  • Technology

    -0.09%

  • Utilities

    -0.67%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…